Your session is about to expire
← Back to Search
Other
Participants requesting test(s) and treatment assessment for CT and NG infection for Gonorrhea
N/A
Waitlist Available
Research Sponsored by Nova Scotia Health Authority
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up determined at the end of the implementation period (approximately 6 months)
Awards & highlights
Study Summary
This trial aims to test a new project in Nova Scotia where pharmacists will help manage and treat Chlamydia and Gonorrhea infections. These infections are becoming more common in Canada, but many
Who is the study for?
This trial is for individuals in Nova Scotia who may have been exposed to sexually transmitted infections, specifically gonorrhea and chlamydia. It's designed to help those without a primary care physician or who live far from urban STI clinics. The study aims to make testing and treatment more accessible.Check my eligibility
What is being tested?
The trial is evaluating a new approach where community pharmacists in Nova Scotia manage the testing (self-swab or urine collection) and treatment of gonorrhea and chlamydia. This includes clinical assessment and prescribing medication if tests come back positive.See study design
What are the potential side effects?
Potential side effects are not detailed here but generally could include discomfort from self-swabbing, possible allergic reactions, or typical antibiotic-related side effects such as stomach upset, diarrhea, or yeast infections.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ determined at the end of the implementation period (approximately 6 months)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~determined at the end of the implementation period (approximately 6 months)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Characteristics of clients accessing the pharmacy-based CT and NG management program using an electronic questionnaire.
Number and proportion of CT and NG tests, respectively, that have positive results.
Number and proportion of participants assessed and treated by a pharmacist.
+4 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Participants requesting test(s) and treatment assessment for CT and NG infectionExperimental Treatment1 Intervention
Chlamydia trachomatis (CT) and Neisseria gonorrhea (NG) self-swab(s) and urine collection for asymptomatic testing by a pharmacist. Selection of swab(s) or urine-based testing will be determined by the individual's sexual risk factors. Participants who have positive CT and/or NG test results will undergo clinical assessment of the CT and/or NG infection by the pharmacist and prescription(s) will be issued for treatment as appropriate.
Find a Location
Who is running the clinical trial?
Nova Scotia Health AuthorityLead Sponsor
257 Previous Clinical Trials
83,714 Total Patients Enrolled
Dalhousie UniversityOTHER
167 Previous Clinical Trials
403,038 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are individuals still able to enroll in this research study at the moment?
"According to the information provided on clinicaltrials.gov, this specific clinical trial is not currently accepting new participants. The trial was first posted on January 1st, 2024 and last updated on January 22nd, 2024. However, there are presently 750 other trials that are actively seeking candidates for participation."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger